Skip to main content

Elsevier Buys Ariadne Genomics

NEW YORK (GenomeWeb News) – Scientific publishing firm Elsevier today announced it is buying the assets of genomics analysis firm Ariadne Genomics for an undisclosed amount.

Headquartered in Rockville, Md., Ariadne's flagship product is Pathway Studio for the analyses of molecular pathways and disease progression. The software suite comprises an integrated data mining and visualization product "that organizes relevant facts and relationships from large document collections of genes, proteins, cell processes, and diseases," Elsevier said in a statement.

Pathway Studio enables visualization of biological relationships spanning biomedical literature and helps researchers interpret experimental results using domain-specific ontologies, taxonomies, and dictionaries.

Ariadne will be integrated with Elsevier's Corporate Markets division.

The Scan

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.